CAPASSO, ANTONELLA
 Distribuzione geografica
Continente #
AS - Asia 128
NA - Nord America 107
EU - Europa 52
SA - Sud America 31
AF - Africa 1
OC - Oceania 1
Totale 320
Nazione #
US - Stati Uniti d'America 100
SG - Singapore 61
CN - Cina 43
BR - Brasile 27
DE - Germania 12
HK - Hong Kong 11
IT - Italia 9
FI - Finlandia 8
RU - Federazione Russa 5
SE - Svezia 5
GB - Regno Unito 4
MX - Messico 4
VN - Vietnam 4
AR - Argentina 3
CA - Canada 3
IN - India 3
PL - Polonia 3
FR - Francia 2
JP - Giappone 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BE - Belgio 1
EC - Ecuador 1
IL - Israele 1
LT - Lituania 1
OM - Oman 1
TJ - Tagikistan 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 320
Città #
Singapore 33
Dallas 15
Ashburn 14
Beijing 11
Hong Kong 11
Los Angeles 10
Shanghai 9
Boardman 6
Hefei 6
Helsinki 4
Moscow 4
Munich 4
Brooklyn 3
New York 3
Nuremberg 3
Querétaro City 3
Rome 3
Warsaw 3
Jiaxing 2
Lappeenranta 2
Orem 2
Seattle 2
Shenzhen 2
São Paulo 2
Tokyo 2
Turku 2
Zhengzhou 2
Alessandria 1
Aparecida de Goiânia 1
Atlanta 1
Boston 1
Brasília 1
Brussels 1
Buffalo 1
Camden 1
Cape Town 1
Caseros 1
Charlotte 1
Chicago 1
City of London 1
Cleveland 1
Coronel Dorrego 1
Cotia 1
Curitiba 1
Da Nang 1
Denver 1
Dushanbe 1
Eldorado do Sul 1
Erechim 1
Falkenstein 1
Frankfurt am Main 1
Garibaldi 1
Guangzhou 1
Guaratinguetá 1
Handan 1
Hangzhou 1
Hanoi 1
Ho Chi Minh City 1
Houston 1
Indiaporã 1
Irati 1
Joinville 1
Kassel 1
Limeira 1
Manaus 1
Manta 1
Mesquita 1
Mexico City 1
Milan 1
Mumbai 1
Muscat 1
New Delhi 1
Nilópolis 1
Ottawa 1
Panorama City 1
Peruíbe 1
Poplar 1
Porciúncula 1
Praia Grande 1
Pune 1
Raleigh 1
San Francisco 1
San Jose 1
Santa Bárbara d'Oeste 1
Santa Clara 1
Simferopol 1
Sorocaba 1
Stockholm 1
São Vicente 1
Toronto 1
Vancouver 1
Videira 1
Vitória 1
Várzea Paulista 1
Vĩnh Tường 1
Washington 1
Yuto 1
Zé Doca 1
Totale 234
Nome #
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL 66
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib 63
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL 56
CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL 56
MINIMAL RESIDUAL DISEASE-DRIVEN TREATMENT INTENSIFICATION WITH SEQUENTIAL ADDITION OF IBRUTINIB TO VENETOCLAX IN R/R CLL 48
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 45
Totale 334
Categoria #
all - tutte 1.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 3 2 0 1 1 0 0 3
2023/202445 4 0 1 5 0 6 1 6 0 3 2 17
2024/2025114 9 4 4 0 10 8 19 19 9 13 4 15
2025/2026165 26 22 9 57 46 5 0 0 0 0 0 0
Totale 334